| Product Code: ETC4720344 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Guyana`s human insulin import market saw significant growth in 2024, with top exporting countries including the USA, Brazil, India, Netherlands, and South Korea. The market concentration remained high, indicating a competitive landscape. The impressive compound annual growth rate (CAGR) of 37.59% from 2020 to 2024 underscores the increasing demand for human insulin in Guyana. Moreover, the remarkable growth rate of 113.31% from 2023 to 2024 highlights the accelerated pace of import shipments, pointing towards a thriving market for diabetes management in the country.

The human insulin market in Guyana is expanding due to the increasing prevalence of diabetes in the country. Insulin is a critical treatment for diabetes, and with the rising number of diabetic patients, the demand for insulin products is growing. As healthcare access improves and awareness of diabetes management increases, the need for reliable and affordable insulin treatments is expected to rise. The market is also influenced by advancements in insulin delivery methods, such as insulin pumps and pens, providing more convenient options for patients.
The human insulin market in Guyana is expanding as the prevalence of diabetes continues to rise. Human insulin is essential for managing Type 1 and Type 2 diabetes, and the increasing number of diabetic patients in Guyana is driving market growth. As healthcare infrastructure improves and access to insulin becomes more widespread, the demand for human insulin is expected to grow, with both domestic production and imports contributing to the markets expansion.
The human insulin market in Guyana is constrained by limited access to affordable healthcare and insulin supplies. The country faces challenges related to inadequate distribution systems, especially in rural areas, and the high cost of insulin production. Additionally, the market struggles with insufficient government funding for diabetes management programs, limiting access to this essential treatment.
Government policies in Guyana ensure the availability of affordable human insulin through public healthcare initiatives. There are regulatory measures in place to ensure that insulin products meet international standards, contributing to the countrys efforts in managing diabetes and improving public health.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Guyana Human Insulin Market Overview |
3.1 Guyana Country Macro Economic Indicators |
3.2 Guyana Human Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Guyana Human Insulin Market - Industry Life Cycle |
3.4 Guyana Human Insulin Market - Porter's Five Forces |
3.5 Guyana Human Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Guyana Human Insulin Market Revenues & Volume Share, By Diabetes Type, 2021 & 2031F |
3.7 Guyana Human Insulin Market Revenues & Volume Share, By Delivery Devices, 2021 & 2031F |
3.8 Guyana Human Insulin Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Guyana Human Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Guyana |
4.2.2 Growing awareness about the benefits of human insulin over animal-based insulin |
4.2.3 Rising healthcare expenditure and improving healthcare infrastructure in Guyana |
4.3 Market Restraints |
4.3.1 High cost associated with human insulin products |
4.3.2 Limited access to healthcare services in remote areas of Guyana |
4.3.3 Lack of skilled healthcare professionals specializing in diabetes management |
5 Guyana Human Insulin Market Trends |
6 Guyana Human Insulin Market Segmentations |
6.1 Guyana Human Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Guyana Human Insulin Market Revenues & Volume, By Analogue Insulin, 2021-2031F |
6.1.3 Guyana Human Insulin Market Revenues & Volume, By Traditional Human Insulin, 2021-2031F |
6.2 Guyana Human Insulin Market, By Diabetes Type |
6.2.1 Overview and Analysis |
6.2.2 Guyana Human Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021-2031F |
6.2.3 Guyana Human Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021-2031F |
6.2.4 Guyana Human Insulin Market Revenues & Volume, By Gestational Diabetes, 2021-2031F |
6.2.5 Guyana Human Insulin Market Revenues & Volume, By Prediabetes, 2021-2031F |
6.3 Guyana Human Insulin Market, By Delivery Devices |
6.3.1 Overview and Analysis |
6.3.2 Guyana Human Insulin Market Revenues & Volume, By Syringes, 2021-2031F |
6.3.3 Guyana Human Insulin Market Revenues & Volume, By Pens, 2021-2031F |
6.3.4 Guyana Human Insulin Market Revenues & Volume, By Pumps, 2021-2031F |
6.3.5 Guyana Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
6.4 Guyana Human Insulin Market, By End-users |
6.4.1 Overview and Analysis |
6.4.2 Guyana Human Insulin Market Revenues & Volume, By Home Healthcare, 2021-2031F |
6.4.3 Guyana Human Insulin Market Revenues & Volume, By Hospitals, 2021-2031F |
6.4.4 Guyana Human Insulin Market Revenues & Volume, By Over The Counter (OTC), 2021-2031F |
6.4.5 Guyana Human Insulin Market Revenues & Volume, By Clinics, 2021-2031F |
6.4.6 Guyana Human Insulin Market Revenues & Volume, By Others, 2021-2031F |
7 Guyana Human Insulin Market Import-Export Trade Statistics |
7.1 Guyana Human Insulin Market Export to Major Countries |
7.2 Guyana Human Insulin Market Imports from Major Countries |
8 Guyana Human Insulin Market Key Performance Indicators |
8.1 Percentage increase in the number of diabetic patients opting for human insulin treatment |
8.2 Adoption rate of advanced insulin delivery devices in Guyana |
8.3 Number of educational campaigns and programs on diabetes management attended by the population |
9 Guyana Human Insulin Market - Opportunity Assessment |
9.1 Guyana Human Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Guyana Human Insulin Market Opportunity Assessment, By Diabetes Type, 2021 & 2031F |
9.3 Guyana Human Insulin Market Opportunity Assessment, By Delivery Devices, 2021 & 2031F |
9.4 Guyana Human Insulin Market Opportunity Assessment, By End-users, 2021 & 2031F |
10 Guyana Human Insulin Market - Competitive Landscape |
10.1 Guyana Human Insulin Market Revenue Share, By Companies, 2024 |
10.2 Guyana Human Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |